Humanwell Healthcare (Group) Co (SHSE:600079) EBIT : ¥3,622 Mil (TTM As of Sep. 2024)

View and export this data going back to 1997. Start your Free Trial

What is Humanwell Healthcare (Group) Co EBIT?

Humanwell Healthcare (Group) Co's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was ¥905 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥3,622 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Humanwell Healthcare (Group) Co's annualized ROC % for the quarter that ended in Sep. 2024 was 11.54%. Humanwell Healthcare (Group) Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 18.81%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Humanwell Healthcare (Group) Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was 8.73%.

Humanwell Healthcare (Group) Co EBIT Historical Data

The historical data trend for Humanwell Healthcare (Group) Co's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Humanwell Healthcare (Group) Co EBIT Chart

Humanwell Healthcare (Group) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

2,631.00

2,812.65

2,775.12

3,902.62

3,737.97

Humanwell Healthcare (Group) Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT	Get a 7-Day Free Trial															809.03	763.04	894.73	1,059.44	904.74

Competitive Comparison of Humanwell Healthcare (Group) Co's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Humanwell Healthcare (Group) Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Humanwell Healthcare (Group) Co's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Humanwell Healthcare (Group) Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Humanwell Healthcare (Group) Co's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

Humanwell Healthcare (Group) Co EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3,622 Mil.

Humanwell Healthcare (Group) Co (SHSE:600079) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Humanwell Healthcare (Group) Co's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

	ROC % (Q: Sep. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2024 )	+	Invested Capital (Q: Sep. 2024 ))	/ count )
=	3916.756 * ( 1 - 19.88% )	/	( (27003.242	+	27366.001)	/ 2 )
=	3138.1049072	/	27184.6215
=	11.54 %

where

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	36580.817	-	5095.842	-	( 4481.733	-	max(0, 13389.313	-	20071.471	+	4481.733	))
=	27003.242

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	37345.934	-	5217.129	-	( 4762.804	-	max(0, 13726.921	-	20487.119	+	4762.804	))
=	27366.001

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Humanwell Healthcare (Group) Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2024		Q: Sep. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	3618.948	/	( ( (10548.709 + max(8574.978, 0))	+	(10545.535 + max(8800.038, 0)) )	/	2 )
=	3618.948	/	( ( 19123.687	+	19345.573 )	/	2 )
=	3618.948	/	19234.63
=	18.81 %

where Working Capital is:

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(9373.284	+	3878.476	+	856.674)	-	(5095.842	+	0	+	437.614)
=	8574.978

	Working Capital		(Q: Sep. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(9740.393	+	3922.532	+	781.957)	-	(5217.129	+	0	+	427.715)
=	8800.038

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Humanwell Healthcare (Group) Co's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2024 )
	=	3621.935	/	41499.691
	=	8.73 %

Humanwell Healthcare (Group) Co EBIT Related Terms

Thank you for viewing the detailed overview of Humanwell Healthcare (Group) Co's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Humanwell Healthcare (Group) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Humanwell Healthcare (Group) Co Ltd (SHSE:600079) » Definitions » EBIT

Traded in Other Exchanges

N/A

Address

No.666 Gaoxin Road, East Lake High-tech Development Zone, Hubei, Hubei Province, Wuhan, CHN, 430075

Website

https://www.humanwell.com.cn

Humanwell Healthcare (Group) Co Ltd is a China-based integrated healthcare solution provider. Being a pharmaceutical company, it provides medicinal products including fertility-regulating drugs, Uygur medicine, traditional Chinese medicine, medical devices, over-the-counter medicines, anti-infection drugs, herbal medicines, and biological products. The organization has a business presence in China and other international countries.

Executives

Wang Xue Hai	Director
Li Jie	Director
Xu Hua Bin	senior management
Du Wen Tao	senior management
Wu Ya Jun	senior management
Deng Xia Fei	Directors, senior managers
Li Li E	senior management
Yu Qun	senior management
Zhang Hong Jie	senior management
Yin Qiang	senior management
Li Qian Lun	senior management
Gai Song Mei	Supervisors
Zhang Xiao Dong	Director
Liu Yi	senior management
Ai Lu Ming	Director

Humanwell Healthcare (Group) Co Headlines

No Headlines